Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Half-Year 2022 Financial and Clinical Trials Update slide image

Half-Year 2022 Financial and Clinical Trials Update

Perjeta Global sales CHFbn CER growth +5% Regional sales CER growth US +1% 2.5 Europe -17% 2.0 1.5 Japan -1% 1.0 0.5 0.0 HY 19 HY 20 HY 21 HY 22 HY 2022 sales of CHF 2,061m • US: Cannibalization from Phesgo • ● EU: Cannibalization from Phesgo International: Accelerated growth in all regions CER=Constant Exchange Rates International +34% Roche 171
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube